Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Shortages (3)
- Advisory bodies and committees (130)
- Scheduling (national classification system) (53)
- Therapeutic goods regulation (41)
- Regulatory compliance (23)
- In Vitro Diagnostic medical devices (IVDs) (20)
- Prescription medicines (19)
- Unique Device Identification (UDI) hub (14)
- Over the counter (OTC) medicines (9)
- Safety (9)
- Manufacturing (8)
- Australian Register of Therapeutic Goods (ARTG) (7)
- Legislation (7)
- Medical devices safety (7)
- Medicine safety (7)
- Non-prescription medicines (6)
- Vaping hub (6)
- Clinical trials (5)
- Registered complementary medicines (3)
- Advanced therapies (2)
- Advertising (2)
- Complementary medicines (2)
- Listed medicines (2)
- Medicinal cannabis hub (2)
- Pharmacovigilance (2)
- Alert/Advisory (1)
- Compliance and enforcement hub (1)
- COVID-19 vaccines (1)
- Import and export (1)
- Labelling and packaging (1)
- TGA conformity assessment certification (1)
Search
3 result(s) found, displaying 1 to 3
-
PresentationsSee the upcoming changes in the PRAC – the new procedure document that will replace the Uniform Recalls Procedure for Therapeutic Goods (URPTG).
-
WebinarsThis webinar provides information on the TGA’s public consultation on the impacts, challenges and opportunities relating to medicine shortages.
-
PresentationsA presentation discussing the lessons learnt from the Actemra (tocilizumab) shortage.